Clinical Trial: Efficacy of Intravenous Oxytocin to Speed Recovery After THA

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07430228) titled 'Efficacy of Intravenous Oxytocin to Speed Recovery After THA' on Feb. 18.

Brief Summary: The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Total Hip Arthroplasty

Intervention: DRUG: intravenous administration of oxytocin

Single administration of oxytocin 26 micrograms administered intravenously over a period of 45 minutes.

DRUG: Placebo

Saline will be administered intravenously over a perio...